Skip to main content

Closed

CBIO: Crescent Biopharma, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-1417.7%

ROIC-102.3%

Financially safe

Stretched

Debt / equity0.01×

Interest coverage0.0×

Current ratio9.66×

Crescent Biopharma, Inc.

CBIONASDAQ Capital Market·USD·Closed

Crescent Biopharma, Inc.

CBIONASDAQ·USD·Closed

$14.47

−3.66%

$14.47

−$0.55 (3.66%)

52W Range

31thpctl

Volume

0.80×avg

Mkt Cap

398.97MUSD

P/E

-0.0TTM

Div Yield

–ann

52W Range

31thpctl

Volume

0.80×avg

Market Cap

398.97MUSD

P/E Ratio

-0.0TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings